Order Article Reprints

Sewastjanow-Silva M, Xiao L, Gonzalez GN, Wang X, Hofstetter W, Swisher S, Mehran R, Sepesi B, Bhutani MS, Weston B, et al. Chemotherapy Plus Atezolizumab Pre- and Post-Resection in Localized Esophageal or Gastroesophageal Junction Adenocarcinomas: A Phase I/II Single-Arm Study. Cancers. 2024; 16(7):1378. https://doi.org/10.3390/cancers16071378

Sewastjanow-Silva, Matheus, Lianchun Xiao, Graciela N. Gonzalez, Xuemei Wang, Wayne Hofstetter, Stephen Swisher, Reza Mehran, Boris Sepesi, Manoop S. Bhutani, Brian Weston, and et al. 2024. "Chemotherapy Plus Atezolizumab Pre- and Post-Resection in Localized Esophageal or Gastroesophageal Junction Adenocarcinomas: A Phase I/II Single-Arm Study" Cancers 16, no. 7: 1378. https://doi.org/10.3390/cancers16071378

Sewastjanow-Silva, M., Xiao, L., Gonzalez, G. N., Wang, X., Hofstetter, W., Swisher, S., Mehran, R., Sepesi, B., Bhutani, M. S., Weston, B., Coronel, E., Waters, R. E., Rogers, J. E., Smith, J., Lyons, L., Reilly, N., Yao, J. C., Ajani, J. A., & Murphy, M. B. (2024). Chemotherapy Plus Atezolizumab Pre- and Post-Resection in Localized Esophageal or Gastroesophageal Junction Adenocarcinomas: A Phase I/II Single-Arm Study. Cancers, 16(7), 1378. https://doi.org/10.3390/cancers16071378